Spectrum of HLA associations: The case of medically refractory pediatric acute lymphoblastic leukemia

Immunogenetics

Volumn 64, Issue 6, 2012, Pages 409-419

  Klitz, William ^a   Gragert, Loren ^b   Trachtenberg, Elizabeth ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL MARROW DONOR PROGRAM   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Acute lymphoblastic leukemia; Allelic polymorphism; HLA; Immunodominance; Mode of inheritance; Pediatric

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HLA A GENE; HLA B GENE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA; PRIORITY JOURNAL; ADOLESCENT; ADULT; GENETICS; IMMUNOLOGY; INFECTION; PRESCHOOL CHILD;

HLA A ANTIGEN; HLA B ANTIGEN; HLA DRB1 ANTIGEN;

ADOLESCENT; ADULT; ALLELES; CHILD, PRESCHOOL; GENOTYPE; HAPLOTYPES; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DRB1 CHAINS; HUMANS; INFECTION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84863996845     PISSN: 00937711     EISSN: 14321211     Source Type: Journal    
DOI: 10.1007/s00251-012-0605-5     Document Type: Article

References (44)

1. Allison AC (1954) Notes on sickle-cell polymorphism. Ann Hum Genet 19:39-51
2. Bashirova AA, Thomas R, Carrington M (2011) HLA/KIR restraint of HIV: surviving the fittest. Annu Rev Immunol 29:295-317
3. Davies SM, Ramsey NKC, Keresy JH (2004) Allogeneic transplantation for acute lymphoblastic leukemia in children. John Wiley & Sons, Hoboken
4. Eden T (2010) Aetiology of childhood leukaemia. Cancer Treat Rev 36:286-297
5. Goldberg JM, Silverman LB, Levy DE, Dalton VK, Gelber RD, Lehmann L, Cohen HJ, Sallan SE, Asselin BL (2003) Childhood T cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience. J Clin Oncol 21:3616-3622 (Pubitemid 46594054)
6. Greaves MF (1988) Speculations on the cause of childhood acute lymphoblastic leukemia. Leukemia 2:120-125 (Pubitemid 18085297)
7. Greaves M (1993) A natural history for pediatric acute leukemia. Blood 82:1043-1051 (Pubitemid 23253975)
8. Greaves MF (1996) Infant leukaemia biology, aetiology and treatment. Leukemia 10:372-377 (Pubitemid 26102900)
9. Greaves MF (1997) Aetiology of acute leukaemia. Lancet 349:344-349 (Pubitemid 27056837)
10. Greaves M (2006) Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 6:193-203 (Pubitemid 43292563)
11. Greaves MF, Alexander FE (1993) An infectious etiology for common acute lymphoblastic leukemia in childhood? Leukemia 7:349-360 (Pubitemid 23093091)
12. Greaves MF, Wiemels J (2003) Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 3:639-649 (Pubitemid 37328819)
13. Hertz T, Nolan D, James I, John M, Guaudieri S, Phillips E, Huang JC, Riadi G, Mallal S, Jojic N (2011) Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins. J Virol 85:1310-1321
14. Hosking FJ, Leslie S, Dilthey A, Moutsianas L, Wang Y, Dobbins SE, Papaemmanuil E, Sheridan E, Kinsey SE, Lightfoot T, Roman E, Irving JA, Allan JM, Taylor M, Greaves M, McVean G, Houlston RS (2011) MHC variation and risk of childhood B-cell precursor acute lymphoblastic leukemia. Blood 117:1633-1640
15. Kinlen L (1988) Evidence for an infective cause of childhood leukaemia: comparison of a Scottish new town with nuclear reprocessing sites in Britain. Lancet 2:1323-1327 (Pubitemid 19004433)
16. Kinlen LJ (1997) High-contact paternal occupations, infection and childhood leukaemia: five studies of unusual population-mixing of adults. Br J Cancer 76:1539-1545 (Pubitemid 27520577)
17. Klitz W, Gragert L, Maiers M, Fernandez-Vina M, Ben-Naeh Y, Benedek G, Brautbar C, Israel S (2010) Genetic differentiation of Jewish populations. Tissue Antigens 76:442-458
18. Lazarski CA, Chaves FA, Jenks SA, Wu S, Richards KA, Weaver JM, Sant AJ (2005) The kinetic stability of MHC class II: peptide complexes is a key parameter that dictates immunodominance. Immunity 23:29-40 (Pubitemid 41019655)
19. Lilly F, Boyse EA, Old LJ (1964) Genetic basis of susceptibility to viral leukaemogenesis. Lancet 2:1207-1209
20. Little J (1999) Epidemiology of childhood cancer. IARC Scientific Publications, Lyon
21. Lynch HT, Thomas RJ, Gurgis HA, Lynch J (1975) Clues to cancer risk: biologic markers. Am Fam Physician 11:153-158
22. Maiers M, Gragert L, Klitz W (2007) High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol 68:779-788 (Pubitemid 47379974)
23. McNally RJ, Eden TO (2004) An infectious aetiology for childhood acute leukaemia: a review of the evidence. Br J Haematol 127:243-263 (Pubitemid 39468939)
24. Nayak JL, Richards KA, Chaves FA, Sant AJ (2010) Analyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins. Viral Immunol 23:169-180
25. O'Connor S, Boneva R (2007) Infectious etiologies of childhood leukemia: plausibility and challenges. Environ Health Perspect 115:146-150 (Pubitemid 46050297)
26. Richeldi L, Kreiss K, Mroz MM et al (1997) Interaction of genetic and exposure factors in the prevalence of chronic beryllium disease among beryllium ceramic workers. Am J Ind Med 32:337-340 (Pubitemid 27330274)
27. Rosenman KD, Rossman M, Hertzberg V, Reilly MJ, Rice C, Kanterakis E, Monos D (2011) HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity. Occup Environ Med 68:487-493
28. Ryder LP, Andersen E, Svejgaard A (1979) HLA and disease registry. Munksgaard, Copenhagen
29. Sendid B, Quinton JF, Charrier G, Goulet O, Cortot A, Grandbastien B, Poulain D, Colombel JF (1998) Anti-saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroen-terol 93:1306-1310 (Pubitemid 29076932)
30. Snyder JA, Demchuk E, McCanlies EC, Schuler CR, Kreiss K, Andrew ME, Frye BL, Ensey JS, Stanton ML, Weston A (2008) Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease. J R Soc Interface 5:749-758 (Pubitemid 351882141)
31. Sokal RR, Rohlf FJ (1995) Biometry: the principles and practice of statistics in biological research. W.H. Freeman & Co., New York
32. Steere AC, Klitz W, Drouin EE, Falk BA, Kwok WW, Nepom GT, Baxter-Lowe LA (2006) Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdor-feri peptide. J Exp Med 203:961-971
33. Taylor GM (1994) Immunogenetics and the aetiology of childhood leukaemia. Arch Dis Child 70:77-81 (Pubitemid 24088954)
34. Taylor GM, Hussain A, Lightfoot TJ, Birch JM, Eden TO, Greaves MF (2008) HLA-associated susceptibility to childhood B-cell precursor ALL: definition and role of HLA-DPB1 supertypes. Br J Cancer 98:1125-1131 (Pubitemid 351399803)
35. Taylor M, Hussain A, Urayama K, Chokkalingam A, Thompson P, Trachtenberg E, Buffler P (2009) The human major histocompat-ibility complex and childhood leukemia: an etiological hypothesis based on molecular mimicry. Blood Cells Mol Dis 42:129-135
36. Thorsby E (1997) HLA associated diseases. Hum Immunol 53:1-11
37. Uckun FM, Sensel MG, Sun L, Steinherz PG, Trigg ME, Heerema NA, Sather HN, Reaman GH, Gaynon PS (1998) Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. Blood 91:735-746 (Pubitemid 28078273)
38. Urayama KY, Ma X, Selvin S, Metayer C, Chokkalingam AP, Wiemels JL, Does M, Chang J, Wong A, Trachtenberg E, Buffler PA (2010) Early life exposure to infections and risk of childhood acute lymphoblastic leukemia. Int J Cancer 128:1632-1643
39. Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Fingerlin TE, Sato H, Newman LS, Maier LA (2011) Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers. Am J Respir Crit Care Med 183:1680-1688
40. Vitale M, Rezzani R, Rodella L, Zauli G, Grigolato P, Cadei M, Hicklin DJ, Ferrone S (1998) HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Res 58:737-742 (Pubitemid 28099486)
41. Vitale M, Pelusi G, Taroni B, Gobbi G, Micheloni C, Rezzani R, Donato F, Wang X, Ferrone S (2005) HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage. Clin Cancer Res 11:67-72 (Pubitemid 40075779)
42. Walford RL, Finkelstein S, Neerhout R, Konrad P, Shanbrom E (1970) Acute childhood leukaemia in relation to the HL-A human transplantation genes. Nature 225:461-462
43. Weaver JM, Sant AJ (2009) Understanding the focused CD4 T cell response to antigen and pathogenic organisms. Immunol ResImmunol. Res 45:123-143
44. Yewdell JW, Bennink JR (1999) Immunodominance in major histo-compatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 17:51-88 (Pubitemid 29241119)